Update this profile
Specific General Information Description
Developer of a small molecule sensor (SMS) array designed to determine the effective antibiotic. The company's product includes an instrument and assay which responds to the metabolic byproducts produced by microorganisms to detect growth, assess antibiotic efficacy and determine microorganism ID, enabling doctors to detect low (part per billion) concentrations of volatile organic compounds (VOCs) in very complex mixtures.
Financing Round Captured Employee Count Estimated Employee Growth
Want to dig into this profile?
We’ll help you find what you need
Specific Valuation & Funding
Raised to Date
4. Later Stage VC (Series A)
To view Specific’s complete valuation and funding history, request access »
0.80%, 93rd %ile
219x, 100th %ile
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
Specific Investors (5)
National Institute for Allergy and Infectious Disease
Telegraph Hill Partners Venture Capital
U.S. Department of Health and Human Services
To view Specific’s complete investors history, request access »